Hologic, Inc. (HOLX) Reports In-Line Q2 EPS; Guides Q3 Below Views
Tweet
Share
E-mailGet Alerts HOLX Hot Sheet
Price: $75.38 +0.37%
Revenue Growth %: -2.5%
Financial Fact:
Research and development: 62.5M
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: -2.5%
Financial Fact:
Research and development: 62.5M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Hologic, Inc. (NASDAQ: HOLX) reported Q2 EPS of $0.33, in-line with the analyst estimate of $0.33. Revenue for the quarter came in at $471.2 million versus the consensus estimate of $474.03 million.
Hologic, Inc. sees Q3 2012 EPS of $0.34, versus the consensus of $0.35. Hologic, Inc. sees Q3 2012 revenue of $475-$480 million, versus the consensus of $481.97 million.
Reaffirms FY12 outlook.
For earnings history and earnings-related data on Hologic, Inc. (HOLX) click here.
Hologic, Inc. sees Q3 2012 EPS of $0.34, versus the consensus of $0.35. Hologic, Inc. sees Q3 2012 revenue of $475-$480 million, versus the consensus of $481.97 million.
Reaffirms FY12 outlook.
For earnings history and earnings-related data on Hologic, Inc. (HOLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Synovus Financial (SNV) PT Lowered to $42 at Piper Sandler
- BCB Bancorp (BCBP) Misses Q1 EPS by 2c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
